Search
for
Sort by
Research 30 of 1000+
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- 6 Peripheral androgens and the role of androstanediol glucuronide
- Hirsutism
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Hirsutism
- Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome
- Hirsutism
- Androstanediolglucuronide: A parameter for peripheral androgen activity before and during therapy with cyproterone acetate
- Markers of peripheral androgen action in vivo and in vitro
- Serum C-19 steroid sulphates in females with clinical hyperandrogenism
- P131 Menstrual irregularity in hirsute women
- [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
- Cutaneous Toxicities From Transplantation-Related Medications
- Recent advances in the treatment of polycystic ovary syndrome
- The SAHA Syndrome
- Anti-Androgens
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Minoxidil oral en alopecias no androgénicas
- Spironolactone in the treatment of hirsutism.
- The influence of androgens on insulin resistance
- 8 Hair follicles and associated glands as androgen targets
- Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Evidence‐Based Treatment of Hirsutism
- The Evaluation and Management of Hirsutism
- Polycystic Ovarian Syndrome
- Oral Contraceptives as Anti-Androgenic Treatment of Acne
- Steroid inhibitors of androgen-potentiated actions on skin
- A benign cause of hyperandrogenism in a postmenopausal woman